Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Respiratory syncytial virus (RSV) infection in conditions classified elsewhere and of unspecified site
0.100 AlteredExpression disease BEFREE In the experiment with RSV-induced BA exacerbation, Immunomax-treated mice were characterized by a significant decrease of the viral load in lung homogenates, an increased amount of M1 macrophages in the lung, a tendency toward Th2-dependent ovalbumin-specific IgG1 antibodies decrease in blood serum, a significant increase in RSV-activated CD4+ T cells secreting IFNγ (Th1 cells), and a simultaneous significant decrease in the amount of CD4<sup>+</sup> cells secreting IL-4 (Th2 cells) in the mouse spleen, which were detected by ELISPOT 1.5 months after experiment. 30713767 2020
Respiratory syncytial virus (RSV) infection in conditions classified elsewhere and of unspecified site
0.100 Biomarker disease BEFREE Factors associated with disease severity were gestational age (odds ratio, 0.49; 95% confidence interval, 0.29-0.82; <i>P</i> = 0.007) and IL-4 (odds ratio, 9.67; 95% confidence interval, 2.45-38.15; <i>P</i> = 0.001).<b>Conclusions:</b> This study shows, for the first time, that elevated levels of ILC2s is associated with infant RSV severity. 31237777 2019
Respiratory syncytial virus (RSV) infection in conditions classified elsewhere and of unspecified site
0.100 Biomarker disease BEFREE In contrast, reduced respiratory syncytial virus-induced IL-8 responses and increased 5'-cytosine-phosphate-guanine-3' (CpG)-induced IL-12p40 and allergen-induced IL-4 responses were associated with atopy. 28089873 2017
Respiratory syncytial virus (RSV) infection in conditions classified elsewhere and of unspecified site
0.100 AlteredExpression disease BEFREE Using a neonatal mouse model, we have shown that down-regulation of IL-4 receptor α (IL-4Rα) with antisense oligonucleotides in the lung during neonatal infection protected from RSV immunopathophysiology. 28389622 2017
Respiratory syncytial virus (RSV) infection in conditions classified elsewhere and of unspecified site
0.100 Biomarker disease BEFREE Intranasal administration of AS1411 (50 mg/kg) to RSV-infected mice and cotton rats was associated with partial reductions in lung viral titers, decreased virus-associated airway inflammation, and decreased IL-4/IFN-γ ratios when compared to untreated, infected animals. 28925950 2017
Respiratory syncytial virus (RSV) infection in conditions classified elsewhere and of unspecified site
0.100 AlteredExpression disease BEFREE Formalin-inactivated RSV immune mice showed high levels of pulmonary inflammatory cytokines, macrophages, IL-4-producing T cells, and extensive histopathology. 26656630 2016
Respiratory syncytial virus (RSV) infection in conditions classified elsewhere and of unspecified site
0.100 GeneticVariation disease BEFREE The frequencies of IL-4 -33 CC, CT and TT were 1.4%, 20.6% and 78%, respectively, in RSV bronchiolitis patients and 2.3%, 35.6% and 62%, respectively, in the controls. 26289664 2016
Respiratory syncytial virus (RSV) infection in conditions classified elsewhere and of unspecified site
0.100 GeneticVariation disease BEFREE Each of the SNPs tested had previously been established to have a functional impact on immune responsiveness and two of the SNPs in the IL4 and IL4R genes had previously been associated with severe RSV bronchiolitis. 24949794 2014
Respiratory syncytial virus (RSV) infection in conditions classified elsewhere and of unspecified site
0.100 Biomarker disease BEFREE Treatment with 131-2G significantly (P ≤ 0.001) decreased the percentage of interleukin-4 (IL-4)-positive CD4 and CD8 cells in RSV-stimulated spleen cells at all times p.i., while the percentage of interferon gamma (IFN-γ) T cells significantly (P ≤ 0.001) increased ≥ 75 days p.i. 24990999 2014
Respiratory syncytial virus (RSV) infection in conditions classified elsewhere and of unspecified site
0.100 Biomarker disease BEFREE Combined anti-IL-4 and anti-RSV siRNAs were able to significantly reduce total cell counts and eosinophilia in bronchoalveolar lavage fluid, development of airway hyperresponsiveness, and airway inflammation and to downregulate IL-4 mRNA expression and RSV viral RNA, but to upregulate IFN-γ levels in lung tissues. 24655063 2014
Respiratory syncytial virus (RSV) infection in conditions classified elsewhere and of unspecified site
0.100 AlteredExpression disease BEFREE During primary respiratory syncytial virus (RSV) infection, anti-Axl mAb treatment significantly increased the number of IFN-γ-producing T cells and NK cells and significantly suppressed RSV replication and whole lung levels of IL-4 and IL-13. 24659691 2014
Respiratory syncytial virus (RSV) infection in conditions classified elsewhere and of unspecified site
0.100 AlteredExpression disease BEFREE Deletion of the NS1, but not NS2, protein resulted in three major effects: (i) an increased activation and proliferation of CD8+ T cells that express CD103, a tissue homing integrin that directs CD8+ T cells to mucosal epithelial cells of the respiratory tract and triggers cytolytic activity; (ii) an increased activation and proliferation of Th17 cells, which have recently been shown to have anti-viral effects and also indirectly attract neutrophils; and (iii) decreased activation of IL-4-producing CD4+ T cells--which are associated with enhanced RSV disease--and reduced proliferation of total CD4+ T cells. 21533073 2011
Respiratory syncytial virus (RSV) infection in conditions classified elsewhere and of unspecified site
0.100 AlteredExpression disease BEFREE Respiratory Syncytial Virus elicited lower levels of interleukin 4, when compared with samples without virus identification. 20685025 2011
Respiratory syncytial virus (RSV) infection in conditions classified elsewhere and of unspecified site
0.100 AlteredExpression disease BEFREE Lung inflammation, IFN-gamma:IL-4 mRNA expression ratios, airway obstruction (AO), and airway hyperreactivity (AHR) were significantly increased in mice inoculated with live RSV. 18828742 2008
Respiratory syncytial virus (RSV) infection in conditions classified elsewhere and of unspecified site
0.100 Biomarker disease BEFREE We therefore tested recombinant RSV (rRSV) candidates expressing prototypic murine Th1 (gamma interferon [IFN-gamma]) or Th2 (interleukin-4 [IL-4]) cytokines, with detailed monitoring of responses to subsequent infections with RSV or (as a control) influenza A virus. 17855518 2007
Respiratory syncytial virus (RSV) infection in conditions classified elsewhere and of unspecified site
0.100 Biomarker disease BEFREE Previously, we reported genetic associations between severe respiratory syncytial virus (RSV) bronchiolitis in infants and polymorphisms in the interleukin (IL)-4 and IL-4 receptor alpha (IL-4Ralpha) genes, providing evidence for involvement of T helper type 2 cytokines in the pathogenesis of RSV bronchiolitis. 14722888 2004
Respiratory syncytial virus (RSV) infection in conditions classified elsewhere and of unspecified site
0.100 GeneticVariation disease BEFREE The IL-4 590T allele was found more frequently among children hospitalized with RSV than expected in the case-control (odds ratio [OR], 1.43; P=.04) and combination (OR, 1.41; P=.02) tests. 12508140 2003
Respiratory syncytial virus (RSV) infection in conditions classified elsewhere and of unspecified site
0.100 AlteredExpression disease BEFREE We showed that both IL-4 and IL-13 activity must be inhibited to modulate G-specific responses resulting in severe RSV-induced disease. 12574374 2003
Respiratory syncytial virus (RSV) infection in conditions classified elsewhere and of unspecified site
0.100 AlteredExpression disease BEFREE These results support the hypothesis that severe RSV disease might be related to increased Th2 response, which is perhaps mediated by overexpression of IL-4, and provide preliminary evidence for a genetic link between severe RSV disease and subsequent wheezing. 12402189 2002
Respiratory syncytial virus (RSV) infection in conditions classified elsewhere and of unspecified site
0.100 Biomarker disease BEFREE Patients hospitalized because of RSV infection had increased numbers of CD16(+) and CD56(bright) cells and had RSV-specific increases in Th1 (interleukin [IL]-2 and interferon-gamma) and Th2 (IL-4 and IL-6) cytokines and CC chemokines (macrophage inflammatory protein [MIP]-1alpha, MIP-1beta, and RANTES [regulated on activation, normally T cell expressed and secreted]) mRNA expression. 11992272 2002
Respiratory syncytial virus (RSV) infection in conditions classified elsewhere and of unspecified site
0.100 Biomarker disease BEFREE Flow cytometry of total pulmonary mononuclear cells isolated 10 days following infection with rRSV/mIL-2 revealed increased levels of CD4(+) T lymphocytes expressing either IFN-gamma or IL-4 compared to those of wt rRSV. 10888656 2000
Respiratory syncytial virus (RSV) infection in conditions classified elsewhere and of unspecified site
0.100 Biomarker disease BEFREE Despite the increased IL-4 and IL-5 production and in contrast to mice primed with VV-G, mice primed with VV-Ftm(-) developed RSV-specific cytotoxic T lymphocytes (CTL) and maintained high levels of gamma interferon production. 10559323 1999
Respiratory syncytial virus (RSV) infection in conditions classified elsewhere and of unspecified site
0.100 Biomarker disease BEFREE To determine this event, we studied production of IL-4 by human conjunctival epithelial cells, after infection with RSV. 9663856 1998
Respiratory syncytial virus (RSV) infection in conditions classified elsewhere and of unspecified site
0.100 AlteredExpression disease BEFREE Lung eosinophilia was also associated with a localized reduction in IFN-gamma and increased IL-4 and IL-5 mRNA transcription as well as elevated RSV specific IgG1 antibody production. 9680139 1998